SCHEMBL2138928

SCHEMBL2138928

C1=CC2CCCC1C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclohexane SCHEMBL17939525 0.85
SCHEMBL7774044 0.85
SCHEMBL36991 0.84
SCHEMBL11183068 0.84
SCHEMBL22129636 0.84
SCHEMBL6065835 0.84
SCHEMBL81839 0.84
SCHEMBL10801124 0.81
Methane SCHEMBL4558431 0.80
SCHEMBL1275896 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109776414-B Bcl-2 protein inhibitor and preparation method and application thereof 山东大学 2022-04-22 CN disclosed
US-8552000-B2 Therapeutic agent for senile dementia DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2013-10-08 US disclosed
US-20120165341-A1 THERAPEUTIC AGENT FOR SENILE DEMENTIA DAINIPPON SUMITOMO PHARMA CO., LTD. 2012-06-28 US disclosed
US-8148379-B2 Use of lurasidone (N-[(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl-methyl]-1-cyclohexylmethyl]-2,3-bicycl[2.2.1]heptanedicarboxyimide) DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-04-03 US disclosed
US-7638532-B2 3-aryloxy-8-aza-bicyclo[3.2.1]oct-6-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors NEUROSEARCH A/S (DK) 2009-12-29 US disclosed
US-20090030035-A1 3-Aryloxy-8-aza-bicyclo[3.2.1]]oct-6-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors NEUROSEARCH A/S (DK) 2009-01-29 US disclosed
US-20080255148-A1 Use of lurasidone (N-[(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl-methyl]-1-cyclohexylmethyl]-2,3-bicycl[2.2.1]heptanedicarboxyimide) DAINPPON SUMITOMO PHARMA CO., LTD. (JP) 2008-10-16 US disclosed
US-20060142276-A1 Therapeutic agent for senile dementia DAINIPPON SUMITOMO PHARMA CO. LTD. (JP) 2006-06-29 US disclosed
EP-1637530-A1 THERAPEUTIC AGENT FOR SENILE DEMENTIA Dainippon Sumitomo Pharma Co., Ltd. (JP) 2006-03-22 EP disclosed
EP-0464846-B1 Imide derivatives, and their production and use SUMITOMO PHARMA (JP) 1998-04-22 EP disclosed
EP-0384694-B1 Sheet or film of cyclo-olefin polymer MITSUI PETROCHEMICAL IND (JP) 1996-09-18 EP disclosed
US-5532372-A Imide derivatives, and their production and use SUMITOMO PHARMACEUTICALS COMPANY, LTD. (JP) 1996-07-02 US disclosed
EP-0464846-A1 Imide derivatives, and their production and use SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1992-01-08 EP disclosed
EP-0384694-A2 Sheet or film of cyclo-olefin polymer MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1990-08-29 EP disclosed
US-4814490-A Organopalladium approaches to prostaglandins IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 1989-03-21 US disclosed
US-4113755-A REACTING A NORBORNENE WITH AN ALKENYL MERCURIC HALIDE AND NOBLE METAL SALT IOWA STATE UNIVERSITY RESEARCH FOUNDATION (US) 1978-09-12 US disclosed